Biocon
Suzana Mohd Jizan is a seasoned professional in the biopharmaceutical and quality control sectors, currently serving as the Senior Director at Biocon since September 2023. Prior to this role, Suzana held the position of QC Manager at Xepa SP from April 2019 to September 2023, leading quality control laboratory functions while ensuring compliance with various international guidelines and standards. Suzana's extensive experience includes serving as QC Manager at Royce Pharma Manufacturing Sdn Bhd, managing R&D analytical processes at Pharmaniaga Berhad, and supervising laboratory operations at GSK Consumer Healthcare India. With a Bachelor of Science in Resource Chemistry from Universiti Malaysia Sarawak, education also includes a Science Matriculation Certificate and SPM from prestigious institutions.
This person is not in any teams
This person is not in any offices
Biocon
21 followers
Biocon Limited is a biopharmaceutical company. The Company focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The Company has developed and taken a range of Novel Biologics, Biosimilars, differentiated Small Molecules and affordable Recombinant Human Insulin and Analogs from Lab to Market. The Company's brands include INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab) and ALZUMAb (Itolizumab), an anti-CD6 monoclonal antibody. It has a pipeline of Biosimilars and Novel Biologics at various stages of development, including Insulin Tregopil, an oral insulin analog.